Prosecution Insights
Last updated: April 19, 2026

Salk Institute For Biological Studies

9 pending office actions

Portfolio Summary

9
Total Pending OAs
2
Final Rejections
7
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18426803 SELECTIVE CELL TARGETING USING ADENOVIRUS AND CHEMICAL DIMERS SINGH, ANOOP KUMAR 1632 Non-Final OA Jan 30, 2024
18302962 SYNTHETIC ADENOVIRUSES TARGETING BONE TISSUE AND USES THEREOF LEONARD, ARTHUR S 1631 Non-Final OA Apr 19, 2023
18028751 PATIENT SELECTION BIOMARKERS FOR TREATMENT WITH ULK INHIBITORS VANHORN, ABIGAIL LOUISE 1636 Non-Final OA Apr 12, 2023
18133237 MEDIA COMPOSITIONS FOR NEURONAL CELL CULTURE CORDAS, EMILY ANN 1632 Final Rejection Apr 11, 2023
18297323 MOTOR NEURON-SPECIFIC EXPRESSION VECTORS ARON, KIMBERLY A 1633 Non-Final OA Apr 07, 2023
18016251 SONOGENETIC STIMULATION OF CELLS EXPRESSING TRPA1 BATES, KEENAN ALEXANDER 1631 Non-Final OA Jan 13, 2023
17637058 COMPOSITIONS AND METHODS FOR IN VIVO GENE EDITING LIPPOLIS, ALEXANDRA ROSE 1637 Non-Final OA Feb 21, 2022
17632658 SYSTEMS AND METHODS FOR DISEASE AND TRAIT PREDICTION THROUGH GENOMIC ANALYSIS VASSELL, MEREDITH ABBOTT 1687 Non-Final OA Feb 03, 2022
17104372 TARGETED GENE ACTIVATION USING MODIFIED GUIDE RNA RAVINDRA, KRISHNA NUGGEHALLI 1636 Final Rejection Nov 25, 2020

Managing Salk Institute For Biological Studies's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month